GLP-1’s cold-chain demand puts logistics operators in the spotlight, with FedEx positioned for niche growth
A new Yahoo Finance analysis argues that the rise of GLP-1 therapies is changing shipping requirements for logistics providers, as more deliveries may need temperature-controlled handling from origin to destination.